APO RESEARCH · REPORT
Covid-19 Serology Testing
Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.
Product & engineering
Understand the product.
Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.
Selected research
Industry Research
Covid-19 Serology Testing Industry Research Report 2026
Market perspective
Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.
North America is the largest consumption place, with a consumption market share nearly 35.21% in 2020. APAC is the second largest consumption place with the consumption market share of 32.43%.
Market competition is intense. Abbott, Guangzhou Wondfo Biotech, BioMedomics, Kantaro, Roche, etc. are the leaders of the industry. The top 5 companies occupied about half of the market in 2019.
Read the full market overview
Among the classification of Covid-19 Serology Testing, the proportion of Chemiluminescent Immunoassay in 2020 is about 73.45%.
Covid-19 Serology Testing is widely used for Hospitals and Third-party laboratory. The most proportion of Covid-19 Serology Testing is Hospitals, and the proportion in 2020 is 52.47%.
Report Scope
This report quantifies the global Covid-19 Serology Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Covid-19 Serology Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Covid-19 Serology Testing Market by Company
Abbott
Guangzhou Wondfo Biotech
BioMedomics
Kantaro
Roche
Cellex
Innovita Biological Technology
Zhejiang Orient Gene Biotech
Ortho Clinical Diagnostics
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
Chembio Diagnostics
Safecare Bio-Tech
Covid-19 Serology Testing Segment by Type
Rapid Diagnostic Test (RDT)
Chemiluminescent Immunoassay
Other
Covid-19 Serology Testing Segment by Application
Hospitals
Third-party laboratory
Covid-19 Serology Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid-19 Serology Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Covid-19 Serology Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid-19 Serology Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Covid-19 Serology Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rapid Diagnostic Test (RDT)
- Chemiluminescent Immunoassay
- Other
Applications
- Hospitals
- Third-party laboratory
Companies covered
- Abbott
- Guangzhou Wondfo Biotech
- BioMedomics
- Kantaro
- Roche
- Cellex
- Innovita Biological Technology
- Zhejiang Orient Gene Biotech
- Ortho Clinical Diagnostics
- Guangdong Hecin-Scientific
- Dynamiker Biotechnology (Tianjin)
- Chembio Diagnostics
- Safecare Bio-Tech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Covid-19 Serology Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Rapid Diagnostic Test (RDT)
- 2.2.3 Chemiluminescent Immunoassay
- 2.2.4 Other
- 2.3 Covid-19 Serology Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Third-party laboratory
- 2.4 Assumptions and Limitations
3 Covid-19 Serology Testing Breakdown Data by Type
- 3.1 Global Covid-19 Serology Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Covid-19 Serology Testing Forecasted Market Size by Type (2027-2032)
4 Covid-19 Serology Testing Breakdown Data by Application
- 4.1 Global Covid-19 Serology Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Covid-19 Serology Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Covid-19 Serology Testing Market Perspective (2021-2032)
- 5.2 Global Covid-19 Serology Testing Growth Trends by Region
- 5.2.1 Global Covid-19 Serology Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Covid-19 Serology Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Covid-19 Serology Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Covid-19 Serology Testing Market Dynamics
- 5.3.1 Covid-19 Serology Testing Industry Trends
- 5.3.2 Covid-19 Serology Testing Market Drivers
- 5.3.3 Covid-19 Serology Testing Market Challenges
- 5.3.4 Covid-19 Serology Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Covid-19 Serology Testing Players by Revenue
- 6.1.1 Global Top Covid-19 Serology Testing Players by Revenue (2021-2026)
- 6.1.2 Global Covid-19 Serology Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Covid-19 Serology Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Covid-19 Serology Testing Head Office and Area Served
- 6.4 Global Covid-19 Serology Testing Players, Product Type & Application
- 6.5 Global Covid-19 Serology Testing Manufacturers Established Date
- 6.6 Global Covid-19 Serology Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Covid-19 Serology Testing Market Size (2021-2032)
- 7.2 North America Covid-19 Serology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Covid-19 Serology Testing Market Size by Country (2021-2026)
- 7.4 North America Covid-19 Serology Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Covid-19 Serology Testing Market Size (2021-2032)
- 8.2 Europe Covid-19 Serology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Covid-19 Serology Testing Market Size by Country (2021-2026)
- 8.4 Europe Covid-19 Serology Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Covid-19 Serology Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Covid-19 Serology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Covid-19 Serology Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Covid-19 Serology Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Covid-19 Serology Testing Market Size (2021-2032)
- 10.2 South America Covid-19 Serology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Covid-19 Serology Testing Market Size by Country (2021-2026)
- 10.4 South America Covid-19 Serology Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Covid-19 Serology Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Covid-19 Serology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Covid-19 Serology Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Covid-19 Serology Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.1.4 Abbott Covid-19 Serology Testing Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 Guangzhou Wondfo Biotech
- 12.2.1 Guangzhou Wondfo Biotech Company Information
- 12.2.2 Guangzhou Wondfo Biotech Business Overview
- 12.2.3 Guangzhou Wondfo Biotech Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.2.4 Guangzhou Wondfo Biotech Covid-19 Serology Testing Product Portfolio
- 12.2.5 Guangzhou Wondfo Biotech Recent Developments
- 12.3 BioMedomics
- 12.3.1 BioMedomics Company Information
- 12.3.2 BioMedomics Business Overview
- 12.3.3 BioMedomics Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.3.4 BioMedomics Covid-19 Serology Testing Product Portfolio
- 12.3.5 BioMedomics Recent Developments
- 12.4 Kantaro
- 12.4.1 Kantaro Company Information
- 12.4.2 Kantaro Business Overview
- 12.4.3 Kantaro Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.4.4 Kantaro Covid-19 Serology Testing Product Portfolio
- 12.4.5 Kantaro Recent Developments
- 12.5 Roche
- 12.5.1 Roche Company Information
- 12.5.2 Roche Business Overview
- 12.5.3 Roche Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.5.4 Roche Covid-19 Serology Testing Product Portfolio
- 12.5.5 Roche Recent Developments
- 12.6 Cellex
- 12.6.1 Cellex Company Information
- 12.6.2 Cellex Business Overview
- 12.6.3 Cellex Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.6.4 Cellex Covid-19 Serology Testing Product Portfolio
- 12.6.5 Cellex Recent Developments
- 12.7 Innovita Biological Technology
- 12.7.1 Innovita Biological Technology Company Information
- 12.7.2 Innovita Biological Technology Business Overview
- 12.7.3 Innovita Biological Technology Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.7.4 Innovita Biological Technology Covid-19 Serology Testing Product Portfolio
- 12.7.5 Innovita Biological Technology Recent Developments
- 12.8 Zhejiang Orient Gene Biotech
- 12.8.1 Zhejiang Orient Gene Biotech Company Information
- 12.8.2 Zhejiang Orient Gene Biotech Business Overview
- 12.8.3 Zhejiang Orient Gene Biotech Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.8.4 Zhejiang Orient Gene Biotech Covid-19 Serology Testing Product Portfolio
- 12.8.5 Zhejiang Orient Gene Biotech Recent Developments
- 12.9 Ortho Clinical Diagnostics
- 12.9.1 Ortho Clinical Diagnostics Company Information
- 12.9.2 Ortho Clinical Diagnostics Business Overview
- 12.9.3 Ortho Clinical Diagnostics Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.9.4 Ortho Clinical Diagnostics Covid-19 Serology Testing Product Portfolio
- 12.9.5 Ortho Clinical Diagnostics Recent Developments
- 12.10 Guangdong Hecin-Scientific
- 12.10.1 Guangdong Hecin-Scientific Company Information
- 12.10.2 Guangdong Hecin-Scientific Business Overview
- 12.10.3 Guangdong Hecin-Scientific Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.10.4 Guangdong Hecin-Scientific Covid-19 Serology Testing Product Portfolio
- 12.10.5 Guangdong Hecin-Scientific Recent Developments
- 12.11 Dynamiker Biotechnology (Tianjin)
- 12.11.1 Dynamiker Biotechnology (Tianjin) Company Information
- 12.11.2 Dynamiker Biotechnology (Tianjin) Business Overview
- 12.11.3 Dynamiker Biotechnology (Tianjin) Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.11.4 Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Product Portfolio
- 12.11.5 Dynamiker Biotechnology (Tianjin) Recent Developments
- 12.12 Chembio Diagnostics
- 12.12.1 Chembio Diagnostics Company Information
- 12.12.2 Chembio Diagnostics Business Overview
- 12.12.3 Chembio Diagnostics Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.12.4 Chembio Diagnostics Covid-19 Serology Testing Product Portfolio
- 12.12.5 Chembio Diagnostics Recent Developments
- 12.13 Safecare Bio-Tech
- 12.13.1 Safecare Bio-Tech Company Information
- 12.13.2 Safecare Bio-Tech Business Overview
- 12.13.3 Safecare Bio-Tech Revenue in Covid-19 Serology Testing Business (2021-2026)
- 12.13.4 Safecare Bio-Tech Covid-19 Serology Testing Product Portfolio
- 12.13.5 Safecare Bio-Tech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst